Browse > Article
http://dx.doi.org/10.4333/KPS.2002.32.4.259

Phonophoretic Delivery of Piroxicam  

Chung, Kyu-Ho (College of pharmacy, Woosuk University)
Kim, Young-Il (Pharmaceutical engineering department, Konyang University)
Yang, Jae-Heon (College of pharmacy, Woosuk University)
Publication Information
Journal of Pharmaceutical Investigation / v.32, no.4, 2002 , pp. 259-265 More about this Journal
Abstract
Piroxicam is one of the NSAID, which is used in the systemic and topical treatment of a variety of inflammatory conditions. Conventionally, for topical use, the drug is formulated in gel. We designed an phonophoretic drug delivery system to investigate the piroxicam permeability and the influence of ultrasound application (continuous mode, pulsed mode), frequency (1.0 MHz, 3.0 MHz) and intensity $(1.0\;w/cm^2,\;1.5\;w/cm^2,\;2.0\;w/cm^2)$ with 0.5% piroxicam gel. Per cutaneous absorption studies were performed in vitro models to determine the rate of drug absorption via the skin. Permeation study using hairless mouse skin was performed at $37^{\circ}C$ using buffered saline (pH 7.4, 10% propylene glycol solution) as the receptor solution. Anti-inflammatory activity was determined using carrageenan-induced foot edema model in rat. A pronounced effect of ultrasound on the skin absorption of the piroxicam was observed at all ultrasound energy level studied. Ultrasound was carried out for 10 hr. The highest permeation was observed at intensity of $2.0\;w/cm^2$, frequency of 1.0 MHz and continuous output. The inclusion of phonophoresis was found to improve significantly the skin permeation in vitro and the anti-inflammatory activity in vivo.
Keywords
Piroxicam; Transdermal delivery; Phonophoresis; Ultrasound; Carrageenan;
Citations & Related Records
연도 인용수 순위
  • Reference
1 C.S. Yong, J.D. Rhee and H.G. Choi, Factors affecting percutaneous absorption, The J.S.B.R., 2, 49-67 (2000)
2 J.E. Riviere and M.C. Heit, Electrically-assisted transdermal drug delivery, Pharm. Res., 14, 687-697 (1997)   DOI   ScienceOn
3 R.R. Burnette, Iontophoresis in transdermal drug delivery, J. Hadgraft and R.H. Cuy (eds.). Marcel Dekker, New York, 247-291 (1989)
4 P. Tyle and P. Agrawala, Drug delivery by phonophoresis, Pharm. Res., 6, 355-359 (1989)   DOI   ScienceOn
5 S. Mitragotri, D. Blankschtein and R. Langer, Transdermal drug delivery using low-frequency sonophoresis, Pharm. Res., 13, 411-420 (1996)   DOI   ScienceOn
6 W.L. Nyborg, Ultrasonic microstreaming and relayed phenomena, Br. J. Cancer, 45, 156-160 (1982)
7 R.L. Bronaugh and H.I. Maibach, Percutaneous absorption. Marcel Dekker, New York, U.S.A., pp. 1-12 (1989)
8 H. Schaefer, A. Zesch and G. Stuttgen, Skin permeability, Springer-Verlag, New York, (1982)
9 P. Schiantarelli and S. Cadel, Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route, Arzneim. Forsch. Drug Res., 31, 87-92 (1981)
10 P. Schiantarelli, S. Cadel, D. Acerbi and L. Pavesi, Anti inflammatory activity and bioavailability of percutaneous piroxicam, Arzneim. Forsch. Drug Res., 32, 230-235 (1982)
11 Y.H. Tsai, L.R. Hsu and S.I. Natio, Percutaneous absorption of piroxicam from ointment bases in rabbits, Int. J. Pharm., 24, 61-78 (1985)   DOI   ScienceOn
12 A.N. Belcastro, G.D. Arthur, T.A. Albisser and D.A. Raj, Heart, liver, and skeletal muscle myeloperoxidase activity during exercise, J. Appl. Physiol., 80, 1331-1335 (1996)   DOI
13 R. Marks and P. Dykes, Plasma and cutaneous levels after topical application of piroxicam gel: a study in healthy volunteers, Skin Pharmacol., 7, 340-344 (1994)   DOI
14 S. Santoyo, A. Arellano, P. Ygartua and C. Martin, Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin, Int. J. Pharm., 117, 219-224 (1995)   DOI   ScienceOn
15 S.C. Shin, C.W. Cho and H.K. Choi, Permeation of piroxicam from the poloxamer gels, Drug Dev. Ind. Pharm., 25, 273-278 (1999)   DOI   ScienceOn
16 D.L. Maclntyre, W.D. Reid, D.M. Lyster and D.C. McKenzie, Different effects of strenuous eccentric exercise on the accumulation of neutrophils in muscle in women and men, Eur. J. Appl. Physiol., 81, 47-53 (2000)   DOI
17 E.L. Nussbaum, Therapeutic ultrasound, Physical Agents Theory and Practice for The Physical Therapist Assistant, Yeongmun Publishing Company, Seoul, 95-102 (1996)
18 R.A. Pedowitz, D.W. Gershuni, J. Friden, S.R. Garfin, B.L. Rydevik and A.R. Hargens, Effects of reperfusion intervals on skeletal muscle injury beneath and distal to a pneumatic tourniquet, J. Hand Surg., 17A, 245-255 (1992)
19 R.A Pedowitz, D.H. Gershuni, A.H. Schmidt, J. Friden, B.L. Rydevik and A.R. Hargens, Muscular injury induced beneath and distal to a pneumatic tourniquet: a quantitative animal study of effects of tourniquet pressure and duration, J. Hand Surg., 16A, 610-621 (1991)
20 A. Bohan and J.B. Peter, Polymyositis and dermatomyositis, New England J. of Medicine, 292, 344-347, 403-407 (1975)   DOI   ScienceOn
21 M.A. Dinno, M. Dyson, S.R. Young, A.J. Mortimer, J. Hart and L.A. Crum, The significance of membrane changes in the safe and effective use of therapeutic and diagnostic ultrasound, Phys. Med. Biol., 34, 1543-1552 (1989)   DOI   ScienceOn
22 E.H. Wiseman, Y.H. Chang and J.G. Lombardino, Piroxicam, a novel anti-inflammatory agent, Arzneim. Forsch. Drug Res., 26, 1300 (1976)
23 A.G. Gilman, T.W. Rall, A.S. Nies and P. Taylor, The pharmacological basis of therapeutics. 8th ed., Pergamon Press, Inc., New York, U.S.A., p.668, (1991)
24 B.J. Yun, E.S. Park and S.C. Chi, Pharmacokinetic and pharmacological evaluation of topical microemulsion preparation containing piroxicam, J. Appl pharmacology, 7, 54-58 (1999)
25 M.H. Cameron and L.G. Monroe, Relative transmission of ultrasound by media customarily used for phonophoresis, Phys. Ther., 72, 142-148 (1992)   DOI
26 D.E. Wilson, K. Kaidbey, S.C. Boike and D.K. Jorkasky, Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin rections associated with testosterone transdermal therapy, Clin. Ther., 20, 299-306 (1998)   DOI   ScienceOn
27 K.F Swingle, T.J. Grant, L.W. Jaques and D.C. Kyam, Interation of anti-inflammatory drugs in carrageenan-induced foot edema of the rat, J. Pharmacol. Exp. Ther., 172, 423-425 (1974)
28 A. Bohan, J.B Peter, R.L. Bowman and C.M. Pearson, A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis, Medicine(Baltimore), 56, 255-286 (1977)